Phoenix RX LLC

• DiclofenacZipsor, Lofena, Cambia · 11 products
• LidocaineXylocaine Mpf, Xylocaine, Lidocaine Viscous · 6 products
• Cyclobenzaprine hydrochlorideAmrix, Tonmya, Fexmid · 5 products
• MethocarbamolRobaxin, Atmeksi, Tanlor · 4 products
• MeloxicamZybic, Xifyrm, Qamzova · 4 products
• Ibuprofen and famotidine3 products
• Naproxen and esomeprazole magnesium3 products
• Ondansetron3 products
• IbuprofenIbu, Caldolor · 2 products
• GabapentinNeurontin, Gralise, Relgaabi · 2 products
• OmeprazolePrilosec · 2 products
• CelecoxibCelebrex, Vyscoxa, Elyxyb - Celecoxib · 2 products
• Omeprazole and sodium bicarbonateZegerid · 2 products
• Pantoprazole sodiumProtonix I.V., Protonix Delayed-Release, Pantoprazole Sodium I.V. · 2 products
• NaproxenNaprelan, Rugby All Day Relief · 2 products
• Metaxalone2 products
• TizanidineZanaflex, Ontralfy · 1 product
• Rabeprazole sodiumAciphex · 1 product
• MethylprednisoloneSolu-Medrol, Medrol · 1 product
• Diclofenac epolamineLicart, Flector, Diclox Patch 30ct · 1 product
• BaclofenGablofen, Lyvispah, Baclofen (Intrathecal) · 1 product

• NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
• ANDA: Abbreviated New Drug Application: how a generic version is approved.

The sponsor is the company that holds the FDA application; it can differ from the labeler.

No recall of these products (by NDC code) appears in the FDA enforcement reports.

1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →